A Focus on Life Sciences
Safeguard Scientifics has a unique and consistent approach to putting capital to work in the life sciences sector. We target capital efficient diagnostic companies that…
Posted by
Safeguard Insights
The Power of emPower!
PixelOptics’ emPower! eyewear is the world’s first and only electronic focusing eyeglasses—focusing faster than the blink of an eye. The technology is embedded inside the lenses and…
Posted by
Opportunity in the Migraine Market for NuPathe
Ninety percent of migraine sufferers experience nausea, while 60 percent experience vomiting because of their migraine. As a result, today’s most common migraine treatments that…
Posted by
The Developing Pet Generics Market: A Look at New Partner Company Putney
In America, there are more than 171 million dogs and cats in over 71 million households. Ninety-six percent of the drugs approved for these pets…
Posted by
Recap: Safeguard Scientifics Investor Day 2011
Earlier this week we held our Fifth Annual Investor Day 2011 where investors and analysts heard presentations from Safeguard executives and highlighted partner companies on…
Posted by
The Elevator Pitch: 30 Seconds to Sell Your Business
I have learned many lessons in my career. One of the most critical — you never have a second chance to make a first impression.…
Posted by
Week in Review: IPOs, Entrepreneurship and 40 Years Trading on the NYSE
More IPO buzz this week. On Wednesday, its first day of trading, Pandora shares were as high as $26. The excitement dwindled a bit on…
Posted by
Communicating Value and Increasing Transparency
Cash on our balance sheet may be growing with every well-timed exit transaction and positive momentum is driving Safeguard’s stock price upward; however, our IR…
Posted by
Safeguard CEO featured on TheStreet.com
Last week, Safeguard Scientifics’ President and CEO Peter J. Boni sat down with Gregg Greenberg of TheStreet.com to discuss the emergence of IPO candidates from…
Posted by
